Prosonix
Latest round
- Series B
Last raised
- Oct 2012
Total raised
- $26M
Investors
- 6
About Prosonix
Founded in 2006 in Oxford, UK, Prosonix develops ultrasonic nebulization solutions for the healthcare sector. The company underwent a significant transformation when it was acquired by Circassia Ltd in May 2015 for GBP 70 million, marking a pivotal change in its operational strategy.uk specializes in advanced ultrasonic nebulizers that efficiently deliver aerosolized medications. These devices convert liquid medications into fine mist particles for inhalation, enhancing treatment efficacy in respiratory therapies. The acquisition by Circassia Ltd in May 2015 has positioned Prosonix for growth, with future initiatives focused on launching new products and entering emerging markets in Asia by 2025.
Who invested in Prosonix
6 investors across 2 rounds
See all investors in Prosonix
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Prosonix
Who invested in Prosonix?
Prosonix has 6 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Prosonix raised?
Prosonix has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did Prosonix last raise money?
Prosonix's most recent round on record is a Series B, in Oct 2012.
What does Prosonix do?
Founded in 2006 in Oxford, UK, Prosonix develops ultrasonic nebulization solutions for the healthcare sector.
Where is Prosonix headquartered?
Prosonix is headquartered in Oxford, UK.
Which VCs invest in companies like Prosonix?
Among active investors with capital left to deploy, Index Ventures, Forbion, European Investment Bank and Generation Investment Management back pharmaceuticals companies at Prosonix's stage. Their profiles are linked below.
VCs backing pharmaceuticals startups at Series B
Raising like Prosonix? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.